99mTc-labeled MIBG derivatives: Novel 99mTc complexes as myocardial imaging agents for sympathetic neurons

Bioconjugate Chemistry

Volumn 10, Issue 2, 1999, Pages 159-168

  Zhuang, Zhi Ping ^a   Kung, Mei Ping ^a   Mu, Mu ^a   Hou, Catherine ^a   Kung, Hank F ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NOREPINEPHRINE; NUCLEAR MEDICINE; RATS; SYNTHESIS (CHEMICAL); TUMORS;

CO-INJECTION; IMAGING AGENT; IN-VIVO IMAGING; MYOCARDIAL INFARCTS; NEUROENDOCRINE TUMORS; NONRADIOACTIVE; PRE-TREATMENTS; RADIOACTIVE IODINE; SYMPATHETIC NERVOUS SYSTEMS; SYNTHESISED;

HEART;

(3 IODOBENZYL)GUANIDINE; DIAGNOSTIC AGENT; DRUG DERIVATIVE; DYES, REAGENTS, INDICATORS, MARKERS AND BUFFERS; RADIOPHARMACEUTICAL AGENT; TECHNETIUM;

ADRENERGIC SYSTEM; ANIMAL; ARTICLE; CELL CULTURE; HEART; HEART MUSCLE; HUMAN; INNERVATION; MALE; METABOLISM; NEUROBLASTOMA; RAT; SCINTISCANNING; SPRAGUE DAWLEY RAT; STRUCTURE ACTIVITY RELATION; SYNTHESIS; TISSUE DISTRIBUTION;

3-IODOBENZYLGUANIDINE; ANIMALS; HEART; HUMANS; INDICATORS AND REAGENTS; MALE; MYOCARDIUM; NEUROBLASTOMA; RADIOPHARMACEUTICALS; RATS; RATS, SPRAGUE-DAWLEY; STRUCTURE-ACTIVITY RELATIONSHIP; SYMPATHETIC NERVOUS SYSTEM; TECHNETIUM; TISSUE DISTRIBUTION; TUMOR CELLS, CULTURED;

EID: 0032587899     PISSN: 10431802     EISSN: None     Source Type: Journal    
DOI: 10.1021/bc970207q     Document Type: Article

References (33)

1. 131I]iodobenzylguanidine. J. Nucl. Med. 21, 349-353.
2. Glowniak, J. V., Kilty, J. E., Amara, S. G., Hoffman, B. J., and Turner, F. E. (1993) Evaluation of metaiodobenzylguanidine uptake by the norepinephrine, dopamine and serotonin transporters. J. Nucl. Med. 34, 1140-1146.
3. Wieland, D. M., Mangner, T. J., Inbasekaran, M. N., Brown, L. E., and Wu, J.-l. (1984) Adrenal medulla imaging agents: a structure-distribution relationship study of radiolabeled aralkylguanidines. J. Med. Chem. 27, 149-155.
4. Shapiro, B., Sisson, J. C., Shulkin, B. L., Gross, M. D., and Zempel, S. (1995) The current status of meta-iodobenzylguanidine and related agents for the diagnosis of neuro-endocrine tumors [review; 60 refs]. Q. J. Nucl. Med. 39, 3-8.
5. Wieland, D. M., Brown, L. E., Rogers, W. L., Worthington, K. C., Wu, J.-L., Clinthorne, N. H., Otto, C. A., Swanson, D. P., and Beierwaltes, W. H. (1981) Myocardial imaging with a radioiodinated norepinephrine storage analogue. J. Nucl. Med. 22, 22-31.
6. Sisson, J. C., Wieland, D. M., Sherman, P., Mangner, T. J., Tobes, M. C., and Jacques, J., S. (1987) Metaiodobenzylguanidine as an index of the adrenergic nervous system integrity and function. J. Nucl. Med. 28, 1620-1624.
7. McGhie, A. I., Corbett, J. R., Akers, M. S., Kulkarni, P., Sills, M. N., Kremers, M., Buja, M. L., Durant-Reville, M., Parkey, R. W., and Willerson, J. T. (1991) Regional cardiac adrenergic function using I-123 meta-iodobenzylguanidine tomographic imaging after acute myocardial infarction. Am. J. Cardiol. 67, 236-242.
8. Kline, R. C., Swanson, D. P., Wieland, D. M., Thrall, J. H., Gross, M. D., Pitt, B., and Beierwaltes, W. H. (1981) Myocardial imaging in man with I-123 metaiodobenzylguanidine. J. Nucl. Med. 22, 129-132.
9. Dae, M. W., O'Connell, J. W., Botvinick, E. H., and Michael, C. (1995) Acute and chronic effects of transient myocardial-ischemia on sympathetic-nerve activity, density, and norepinephrine content. Cardiovasc. Res. 30, 270-280.
10. Demarco, T., Dae, M., Yuengreen, M. S. F., Kumar, S., Sudhir, K., Keith, F., Amidon, T. M., Rifkin, C., Lau, D., Botvinick, E. H., and Chatterjee, K. (1995) I-123 metaiodobenzylguanidine scintigraphic assessment of the transplanted human heart: evidence for late reinnervation. J. Am. Coll. Cardiol. 25, 927-931.
11. Merlet, P., Caussin, C., Poiseau, E., Piot, O., Mazière, B., and Syrota, A. (1996) In vivo assessment of neurotransmitter system in cardiovascular diseases. Clinical issues [review]. Q. J. Nucl. Med. 40, 108-120.
12. Dae, M. W. (1995) Scintigraphy of myocardial innervation with metaiodobenzylguanidine (MIBG): is there a clinical application? [editorial]. J. Nucl. Cardiol. 2, 151-154.
13. 123I]-MIBG) in patients with myocardial infarct. Eur. J. Nucl. Med. 15, 624-628.
14. Fagret, D., Wolf, J.-E., Vanzetto, G., and Borrel, E. (1993) Myocardial uptake of metaiodobenzylguanidine in patients with left ventricular hypertrophy secondary to valvular aortic stenosis. J. Nucl. Med. 34, 57-60.
15. Merlet, P., Valette, H., Dubois-Randé, J. L., Moyse, D., Duboc, D., Dove, P., Bourguignon, M., Benvenuti, C., Duval, A.-M., Agostini, D., Loisance, D., Castaigne, A., and Syrota, A. (1992) Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure. J. Nucl. Med. 33, 471-477.
16. Schnell, O., Muhr, D., Dresel, S., Weiss, M., Haslbeck, M., and Standl, E. (1997) Partial restoration of scintigraphically assessed cardiac sympathetic denervation in newly diagnosed patients with insulin-dependent (type 1) diabetes mellitus at one-year follow-up. Diabetic Med. 14, 57-62.
17. 123I-metaiodobenzylguanidine uptake in newly diagnosed IDDM patients. Diabetes 45, 801-805.
18. Kung, H. F., Kim, H.-J., Kung, M.-P., Meegalla, S. K., Plössl, K., and Lee, H.-K. (1996) Imaging of dopamine transporters in humans with technetium-99m TRODAT-1. Eur. J. Nucl. Med. 23, 1527-1530.
19. Walovitch, R. C., Hill, T. C., Garrity, S. T., Cheesman, E. H., Burgess, B. A., O'Leary, D. H., Watson, A. D., Ganey, M. V., Morgan, R. A., and Williams, S. J. (1989) Characterization of technetium-99m-L,L-ECD for brain perfusion imaging, Part 1: Pharmacology of technetium-99m ECD in nonhuman primates. J. Nucl. Med. 30, 1892-1901.
20. Léveillé, J., Demonceau, G., DeRoo, M., Rigo, P., Taillefer, R., Morgan, R. A., Kupranick, D., and Walovitch, R. C. (1989) Characterization of technetium-99m-L,L-ECD for brain perfusion imaging, Part 2: biodistribution and brain imaging in humans. J. Nucl. Med. 30, 1902-1910.
21. 99mTc]-L,L-ethyl cysteinate dimer in healthy volunteers. Neuropharmacology 30, 283-292.
22. Meegalla, S. K., Plössl, K., Kung, M.-P., Chumpradit, S., Stevenson, D. A., Kushner, S. A., McElgin, W. T., Mozley, P. D., and Kung, H. F. (1997) Synthesis and characterization of Tc-99m labeled tropanes as dopamine transporter imaging agents. J. Med. Chem. 40, 9-17.
23. 123I-mIBG in rats. Nucl. Med. Commun. 9, 663-667.
24. Kung, H. F., Molnar, M., Billings, J. J., Wicks, R., and Blau, M. (1984) Synthesis and biodistribution of neutral lipid-soluble Tc-99m complexes that cross the blood-brain barrier. J. Nucl. Med. 25, 326-332.
25. Kung, H. F., Yu, C. C., Billings, J. J., Molnar, M., and Blau, M. (1985) Synthesis of new bis-aminoethanethiol (BAT) derivatives: possible ligands for Tc-99m brain imaging agents. J. Med. Chem. 28, 1280-1284.
26. Biedler, J. L., Helson, L., and Sprengler, B. A. (1973) Morphology and growth, tumorigenicity and cytogenetics of human neuroblastoma cells in continuous culture. Cancer Res. 33, 2643-2652.
27. Vaidyanathan, G., Zhao, X.-G., Strickland, D. K., and Zalutsky, M. R. (1997) No-carrier-added iodine-131-FIBG: evaluation of an MIBG analogue. J. Nucl. Med. 38, 330 -334.
28. Gu, H., Wall, S. C., and Rudnick, G. (1994) Stable expression of biogenic amine transporters reveals differences in inhibitor sensitivity, kinetics, and ion dependence. J. Biol. Chem. 269, 7124-7130.
29. Monache, G. D., Botta, B., Delle Monache, F., Espinal, R., De Bonnevaux, S. C., De Luca, C., Botta, M., Corelli, F., and Carmignan, M. (1993) Novel hypotensive agents from Verbesina caracasana. 2. Synthesis and pharmacology of caracasanamide. J. Med. Chem. 36, 2956-2963.
30. 2) complexes for developing new brain imaging agents. Nucl. Med. Biol. 25, 135-140.
31. 2 complexes as myocardial perfusion imaging agents. J. Med. Chem. 35, 157-162.
32. 131I]iodobenzylguanidine. Int. J. Radiat. Appl. Instrum., Part A, Appl. Radiat. Isot. 44, 621-628.
33. 123I]iodobenzylguanidine: synthesis and preliminary evaluation. Nucl. Med. Biol. 22, 61-64.